WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time.
Shared 3 months ago
15 views
Shared 3 months ago
13 views
Shared 3 months ago
19 views
Shared 3 months ago
6 views
Shared 5 months ago
115 views
Shared 9 months ago
116 views
Shared 9 months ago
190 views
Shared 9 months ago
141 views
Shared 9 months ago
87 views
Shared 9 months ago
66 views
Shared 9 months ago
34 views
Shared 9 months ago
122 views
Shared 9 months ago
49 views
Shared 9 months ago
120 views
Shared 10 months ago
294 views
Shared 10 months ago
70 views
Shared 10 months ago
48 views
A Global Village for Global Impact: Talk with Michael Altorfer, CEO of the Swiss Biotech Association
Shared 10 months ago
60 views
Shared 10 months ago
54 views
Shared 3 years ago
33 views
Shared 3 years ago
110 views
Shared 3 years ago
49 views
Shared 3 years ago
55 views
Shared 3 years ago
13 views
Shared 3 years ago
34 views
Shared 3 years ago
12 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy (Christopher Missling)
Shared 3 years ago
192 views
Shared 3 years ago
10 views
Shared 3 years ago
57 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy Adrian Newman-Tancredi
Shared 3 years ago
12 views
Shared 3 years ago
41 views
Shared 3 years ago
48 views
Shared 3 years ago
25 views
Shared 3 years ago
8 views
Shared 3 years ago
13 views
Shared 3 years ago
12 views
Shared 3 years ago
8 views
Shared 3 years ago
34 views
Shared 3 years ago
59 views
Shared 3 years ago
6 views
Shared 3 years ago
22 views
Shared 3 years ago
5 views
Shared 3 years ago
6 views
Shared 3 years ago
14 views